• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1168例肺癌患者初始诊断与治疗的临床研究。

Clinical investigation into the initial diagnosis and treatment of 1,168 lung cancer patients.

作者信息

Shao Qian, Li Jianbin, Li Fengxiang, Wang Suzhen, Wang Wei, Liu Shanshan, Zhang Yingjie

机构信息

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong 250117, P.R. China.

出版信息

Oncol Lett. 2015 Feb;9(2):563-568. doi: 10.3892/ol.2014.2777. Epub 2014 Dec 8.

DOI:10.3892/ol.2014.2777
PMID:25621024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4301476/
Abstract

The aim of the present study was to analyse clinical data obtained from lung cancer patients, including the initial clinical symptoms upon diagnosis, duration of patient delay in presenting to a doctor, lung cancer stage, treatment strategy and prognosis. A retrospective analysis was conducted of the clinical features of 1,168 lung cancer patients who were initially diagnosed and treated at the Tumor Hospital of Shandong Province (Jinan, China) in 2009. The Kaplan-Meier method and multivariate Cox regression analysis were performed to analyse the influence of gender, age, predominant symptoms, histopathological or cytological type and clinical staging on the overall patient survival. The follow-up rate of the present study was 92.4%, and the 1-, 2- and 3-year survival rates were 80.4, 44.9 and 15.8%, respectively. Multivariate analysis demonstrated that the patient age, extent of the tumour (T stage), extent of lymph node spread (N stage), overall clinical stage and treatment strategy were independent risk factors associated with patient survival. The present study identified that the initial symptoms of lung cancer varied, patient delay was long, the lung cancer cases were diagnosed in late clinical stages and the prognosis was poor.

摘要

本研究的目的是分析从肺癌患者获得的临床数据,包括诊断时的初始临床症状、患者就诊延迟的时间、肺癌分期、治疗策略和预后。对2009年在山东省肿瘤医院(中国济南)首次诊断和治疗的1168例肺癌患者的临床特征进行了回顾性分析。采用Kaplan-Meier法和多因素Cox回归分析,分析性别、年龄、主要症状、组织病理学或细胞学类型以及临床分期对患者总生存的影响。本研究的随访率为92.4%,1年、2年和3年生存率分别为80.4%、44.9%和15.8%。多因素分析表明,患者年龄、肿瘤范围(T分期)、淋巴结转移范围(N分期)、总体临床分期和治疗策略是与患者生存相关的独立危险因素。本研究发现,肺癌的初始症状各不相同,患者就诊延迟时间长,肺癌病例在临床晚期被诊断,预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/695f1009d153/OL-09-02-0563-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/212d38b23878/OL-09-02-0563-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/7f5a56476069/OL-09-02-0563-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/d9c42684b221/OL-09-02-0563-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/695f1009d153/OL-09-02-0563-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/212d38b23878/OL-09-02-0563-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/7f5a56476069/OL-09-02-0563-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/d9c42684b221/OL-09-02-0563-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd1e/4301476/695f1009d153/OL-09-02-0563-g03.jpg

相似文献

1
Clinical investigation into the initial diagnosis and treatment of 1,168 lung cancer patients.1168例肺癌患者初始诊断与治疗的临床研究。
Oncol Lett. 2015 Feb;9(2):563-568. doi: 10.3892/ol.2014.2777. Epub 2014 Dec 8.
2
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer.539例IV期肺癌患者初始诊断与治疗的临床研究。
Onco Targets Ther. 2017 Jan 31;10:535-541. doi: 10.2147/OTT.S125108. eCollection 2017.
3
[Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei 
and Fuyuan Counties in Eastern Yunnan Province, China].[中国云南省东部宣威和富源县农村女性非吸烟肺癌患者的生存情况]
Zhongguo Fei Ai Za Zhi. 2019 Aug 20;22(8):477-487. doi: 10.3779/j.issn.1009-3419.2019.08.01.
4
[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].基于分期分类的非小细胞肺癌完全手术切除后的预后
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268.
5
[Prognostic factors of lymph node-negative metastasis gastric cancer].[淋巴结阴性转移性胃癌的预后因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194.
6
[Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].基于多中心、大容量数据库的胃癌手术治疗相关数据整合与分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Feb;19(2):179-85.
7
Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.淋巴结阴性非小细胞肺癌:1765 例连续病例的病理分期和生存情况。
J Thorac Oncol. 2011 Oct;6(10):1691-6. doi: 10.1097/JTO.0b013e31822647fd.
8
[Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].[Ⅲ期结肠癌中肿瘤结节TNM分期方法的预后价值及初步探索性研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Dec 25;22(12):1152-1158. doi: 10.3760/cma.j.issn.1671-0274.2019.12.010.
9
[Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].[525例中国弥漫性大B细胞淋巴瘤患者的预后分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Jun 18;46(3):405-11.
10
Delay in diagnosis and treatment of symptomatic breast cancer in China.中国有症状乳腺癌的诊断和治疗延迟情况。
Ann Surg Oncol. 2015 Mar;22(3):883-8. doi: 10.1245/s10434-014-4076-9. Epub 2014 Sep 12.

引用本文的文献

1
A Prospective Exploratory Study of Functional Immunity Assessed by Pretreatment Interferon Gamma Release Assay in Relation to Different Systemic Therapies in Patients With Advanced-Stage NSCLC.一项关于晚期非小细胞肺癌患者中,通过预处理干扰素γ释放试验评估的功能免疫与不同全身治疗相关性的前瞻性探索性研究。
JTO Clin Res Rep. 2025 May 15;6(8):100845. doi: 10.1016/j.jtocrr.2025.100845. eCollection 2025 Aug.
2
Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness.低剂量计算机断层扫描肺癌筛查:国家支出与成本效益。
Front Public Health. 2022 Sep 29;10:977550. doi: 10.3389/fpubh.2022.977550. eCollection 2022.
3

本文引用的文献

1
Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.基于监测、流行病学和最终结果(SEER)登记处的肺癌分期及临床/预后因素分析:美国癌症联合委员会(AJCC)分期与协作分期数据收集系统
Cancer. 2014 Dec 1;120 Suppl 23(0 0):3781-92. doi: 10.1002/cncr.29045.
2
The importance of screening for lung cancer.肺癌筛查的重要性。
Expert Rev Respir Med. 2014 Oct;8(5):597-614. doi: 10.1586/17476348.2014.937428. Epub 2014 Aug 27.
3
Clinical-epidemiological study on advanced non-small cell lung cancer.
Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.
天津市肺癌计算机断层扫描筛查与管理方法:一项基于人群队列研究的设计
Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.
4
Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.中国城市低剂量计算机断层扫描筛查肺癌的死亡率结果:一项决策分析及对实践的启示
Chin J Cancer. 2017 Jul 14;36(1):57. doi: 10.1186/s40880-017-0221-8.
5
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer.539例IV期肺癌患者初始诊断与治疗的临床研究。
Onco Targets Ther. 2017 Jan 31;10:535-541. doi: 10.2147/OTT.S125108. eCollection 2017.
6
ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer.ATP酶抑制因子1的表达是非小细胞肺癌的一个独立预后因素。
Am J Cancer Res. 2016 May 1;6(5):1141-8. eCollection 2016.
7
Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study.在一项随机对照研究中,对局部晚期非小细胞肺癌进行评估,采用针对肺部病变的靶向经皮微波消融联合纵隔放疗,同时或不同时进行化疗。
Med Oncol. 2015 Sep;32(9):227. doi: 10.1007/s12032-015-0672-1. Epub 2015 Aug 5.
Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):492-6.
4
Resection for subcentimeter non-small cell lung cancer: outcomes for a Chinese population with 70% adenocarcinoma.
J Surg Oncol. 2014 Sep;110(3):225-6. doi: 10.1002/jso.23709. Epub 2014 Jun 27.
5
Surgical management of advanced non-small cell lung cancer.晚期非小细胞肺癌的外科治疗
J Thorac Dis. 2014 May;6 Suppl 2(Suppl 2):S217-23. doi: 10.3978/j.issn.2072-1439.2014.04.34.
6
Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers.非小细胞肺癌:晚期疾病的治疗:化疗药物与新前沿
Semin Intervent Radiol. 2013 Jun;30(2):191-8. doi: 10.1055/s-0033-1342961.
7
Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.用低剂量计算机断层扫描进行肺癌筛查:系统评价以更新美国预防服务工作组的建议。
Ann Intern Med. 2013 Sep 17;159(6):411-420. doi: 10.7326/0003-4819-159-6-201309170-00690.
8
The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.表皮生长因子受体基因突变的存在不是非小细胞肺癌手术后长期预后的一个预测因素。
J Thorac Oncol. 2013 Feb;8(2):171-8. doi: 10.1097/JTO.0b013e318277a3bb.
9
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.吸烟状况与国家综合癌症网络非小细胞肺癌队列的生存情况。
Cancer. 2013 Feb 15;119(4):847-53. doi: 10.1002/cncr.27824. Epub 2012 Sep 28.
10
[Application value of low-dose computed tomography for the screening of lung cancer in high-risk group].低剂量计算机断层扫描在高危人群肺癌筛查中的应用价值
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Jul;43(4):584-7.